Attached files
file | filename |
---|---|
EX-99.3 - EXHIBIT 99.3 - CVD EQUIPMENT CORP | ex_102931.htm |
EX-99.1 - EXHIBIT 99.1 - CVD EQUIPMENT CORP | ex_102897.htm |
8-K/A - FORM 8-K/A - CVD EQUIPMENT CORP | cvv20180111_8ka.htm |
Exhibit 99.2
Mesoscribe Technologies, Inc.
Balance Sheet
As of June 30, 2017
2017 |
||||
ASSETS |
||||
Current Assets |
||||
Cash and cash equivalents |
$ | 303,684 | ||
Accounts receivable, net |
70,689 | |||
Inventory |
95,579 | |||
Accrued revenue |
94,000 | |||
Deferred tax asset |
231,660 | |||
Prepaid corporate taxes |
82,836 | |||
Prepaid expenses |
30,169 | |||
Total Current Assets |
908,617 | |||
Property and equipment, net |
92,367 | |||
Goodwill |
100,000 | |||
Patents, net |
28,117 | |||
Security deposit |
36,072 | |||
Total Assets |
$ | 1,165,173 | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||
Current Liabilities |
||||
Accounts payable |
$ | 3,010 | ||
Accrued expenses |
109,438 | |||
Deferred income taxes |
4,126 | |||
Total Current Liabilities |
116,574 | |||
Shareholder loan |
20,743 | |||
Total Liabilities |
137,317 | |||
Stockholders’ Equity: |
||||
Common stock - $0.01 par value – 20,000,000 shares authorized at June 30, 2017 and September 30, 2016: issued and outstanding 10,500,000 at |
||||
June 30, 2017 and at September 30, 2016 |
10,500 | |||
Additional paid-in capital |
16,109 | |||
Retained earnings |
1,001,247 | |||
Total Stockholders’ Equity |
1,027,856 | |||
Total Liabilities and Stockholders’ Equity |
$ | 1,165,173 |
Mesoscribe Technologies, Inc.
Statement of Operations and Retained Earnings
For the Three and Nine Months Ended June 30, 2017
Three months |
Nine months |
|||||||
Ended June 30, 2017 |
Ended June 30, 2017 |
|||||||
Revenue |
$ | 181,061 | $ | 640,252 | ||||
Cost of revenue |
73,324 | 276,476 | ||||||
Gross profit |
107,737 | 363,775 | ||||||
General and Administrative expenses |
213,184 | 615,491 | ||||||
Total General and Administrative Expenses |
213,184 | 615,491 | ||||||
Operating (loss) |
(105,447 | ) | (251,716 | ) | ||||
Other income (expense): |
||||||||
Interest income |
45 | 145 | ||||||
Deferred tax income |
42,015 | 100,709 | ||||||
Penalties |
(70 | ) | (147 | ) | ||||
Total other (expense)/income net |
41,989 | 100,706 | ||||||
(Loss) before income tax expense |
(63,459 | ) | (151,010 | ) | ||||
Income tax expense |
--- | 1,100 | ||||||
Net (loss) |
$ | (63,459 | ) | $ | (152,110 | ) | ||
Retained Earnings, Beginning of year |
1,064,706 | 1,153,357 | ||||||
Retained Earnings, End of year |
1,001,247 | 1,001,247 |
Mesoscribe Technologies, Inc.
Statements of Cash Flows
For the Three and Nine Months ended June 30, 2017
Three Months |
Nine Months |
|||||||
Ended June 30, |
Ended June 30, |
|||||||
2017 |
2017 |
|||||||
Cash flows from operating activities: |
||||||||
Net (loss) |
$ | (63,459 | ) | $ | (152,110 | ) | ||
Adjustments to reconcile net (loss)/income to net cash used in operating activities |
||||||||
Depreciation and amortization |
7,784 | 23,352 | ||||||
Deferred income tax benefit |
(39,437 | ) | (93,143 | ) | ||||
Increase/(decrease) in operating assets |
||||||||
Accounts receivable |
37,984 | 167,411 | ||||||
Inventory, net |
(512 | ) | (2,145 | ) | ||||
Accrued revenue |
(94,000 | ) | (94,000 | ) | ||||
Other current assets |
(10,367 | ) | (18,708 | ) | ||||
Increase/(decrease) in operating liabilities |
||||||||
Accounts payable |
72 | (986 | ) | |||||
Accrued expenses |
5,050 | (16,709 | ) | |||||
Accrued litigation settlement |
--- | |||||||
Deferred revenue |
--- | (96,759 | ) | |||||
Total adjustments |
(93,426 | ) | (131,687 | ) | ||||
Net cash used in operating activities |
(156,885 | ) | (283,797 | ) | ||||
Cash flows from investing activities: |
||||||||
Capital expenditures |
--- | 2,483 | ||||||
Net cash (used in) investing activities |
--- | 2,483 | ||||||
Cash flows from financing activities |
||||||||
Net cash provided by/(used in) financing activities |
--- | --- | ||||||
Net (decrease)/increase in cash |
(156,885 | ) | (281,314 | ) | ||||
Cash – Beginning of year |
460,570 | 584,999 | ||||||
Cash – End of year |
$ | 303,684 | $ | 303,684 | ||||
Supplemental disclosure of cash flow information |
||||||||
Interest expenses |
--- | --- | ||||||
Income taxes |
--- | 1,100 |